Alopecia areata in children

Childhood alopecia areata can severely affect quality of life and data are lacking regarding the use of methotrexate in this group of patients

These researchers therefore investigated the safety and efficacy of methotrexate in children with severe alopecia areata. This retrospective study included 14 children aged eight to 18 years who had alopecia areata for a mean duration of 5.7 years. The children received treatment once a week at a mean dose of 18.9mg for a mean duration of 14.2 months. Methotrexate treatment was considered successful in five of the 13 children who were assessed; the remainder were regarded as treatment failures. Methotrexate could cautiously be considered for severe alopecia areata, although further studies are needed to prove its efficacy.
Royer M, Bodemer C, Vabres P et al. Br J Dermatol 2011; 165: 407-10

Want news like this straight to your inbox?
Sign up for our bulletins

Read these next

Non-scarring hair loss and its treatment

Hair loss can be distressing, particularly for women...

Case Study: Contact immunotherapy in alopecia areata

Case Study: Contact immunotherapy in alopecia areata

Therapeutic options for alopecia areata are limited,...

Ethnic skin and hair disorders

Ethnic skin and hair disorders

Disease in patients with pigmented skin can present...


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases